Phase I Dose Finding Study of Sorafenib in Combination With Radiation Therapy and Temozolomide as a First Line Treatment of Patients With High Grade Glioma.
Phase of Trial: Phase I
Latest Information Update: 06 Nov 2014
At a glance
- Drugs Sorafenib (Primary) ; Temozolomide
- Indications Glioma
- Focus Adverse reactions
- 31 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Aug 2011 Planned end date changed from 1 Mar 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 24 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.